​

SenesTech Stock (NASDAQ:SNES)

RevenueOwnershipFinancialsChartTranscripts
SenesTech by TradingView

Previous Close

$4.60

52W Range

$1.30 - $6.24

50D Avg

$4.79

200D Avg

$3.19

Market Cap

$24.34M

Avg Vol (3M)

$180.63K

Beta

0.21

Div Yield

-

SNES Company Profile

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Show More

Industry

Chemicals - Specialty

Sector

Basic Materials

Exchange

NASDAQ

ADR

-

Country

US

Employees

23

IPO Date

Dec 08, 2016

Website

SNES Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 22
Grant Revenue-
Product Sales$1.02M

Fiscal year ends in Dec 24 | Currency in USD

SNES Financial Summary

Dec 24Dec 23Dec 22
Revenue$1.86M$1.19M$1.02M
Operating Income$-6.25M$-7.73M$-9.67M
Net Income-$-7.71M$-9.71M
EBITDA$-6.25M$-7.57M$-9.51M
Basic EPS$-8.86$-11.51$-186.39
Diluted EPS$-8.86$-115.10$-186.39

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q2 25Aug 08, 25 | 5:00 PM
Q1 25May 11, 25 | 5:00 PM
Q4 24Mar 12, 25 | 5:00 PM

Peer Comparison

TickerCompany
SPCBSuperCom Ltd.
XBIOXenetic Biosciences, Inc.
TENXTenax Therapeutics, Inc.
BCPCBalchem Corporation
NEUNewMarket Corporation
CRKNCrown ElectroKinetics Corp.